Malaysia

104,700 courses of Paxlovid available for Covid-19 patients: MoH

Drug to be offered for free at CACs, government hospitals, says health minister

Updated 4 years ago · Published on 14 Apr 2022 6:10PM

104,700 courses of Paxlovid available for Covid-19 patients: MoH
Health Minister Khairy Jamaluddin says the Pfizer Covid-19 drug Paxlovid will be offered to treat Categories 2 and 3 patients above the ages of 18 who do not require oxygen therapy and are at risk of experiencing severe symptoms. – AFP pic, April 14, 2022

by Arjun Mohanakrishnan

KUALA LUMPUR – Pfizer’s Covid-19 drug Paxlovid will be offered for free after the Health Ministry has obtained 104,700 courses recently.

In a press conference in the Parliament building today, Health Minister Khairy Jamaluddin said Paxlovid will only be available at Covid-19 Assessment Centres (CACs) and government hospitals.

Some 48,000 courses arrived in Malaysia on April 9 and have been sent to 14 locations in the country, with more to be delivered to Sabah and Sarawak tomorrow.

“These deliveries involve 481 CAC health clinics and 15 government hospitals.”

He said the Drug Control Authority on March 3 gave a conditional approval for Paxlovid, adding that the medication will reduce the virus’ ability to replicate itself and improve the body’s immune system to fight the infection.

Paxlovid will be offered to treat Categories 2 and 3 Covid-19 patients above the ages of 18 who do not require oxygen therapy and are at risk of experiencing severe symptoms.

Covid-19 patients that arrive at CACs or government hospitals will be screened and assessed by a medical officer before receiving the drug.

Patients that are given a score above three during the assessment will be given priority for the antiviral treatment.

“Priority will be given to senior citizens infected with Covid-19, patients with various comorbidities and the immunocompromised.”

He said the drug must be taken within five days of experiencing symptoms for optimum efficacy and patients must take two pills a day for a period of five days.

He added that Paxlovid can reduce deaths and hospitalisation by up to 90%, but it should not be used to replace Covid-19 vaccinations. – The Vibes, April 14, 2022

Related News

Malaysia / 2w

Covid-19 cases in Malaysia stable, no deaths recorded this year – MOH

Malaysia / 3mth

Bad move to channel EPF dividends into Account 3 for festive withdrawals, cautions economist

Opinion / 7mth

A tale of two administrations: How Warisan and GRS shaped Sabah’s future

Malaysia / 1y

MOH closely monitoring Covid-19 amid rising cases in neighbouring countries

Opinion / 1y

The Trump dilemma and reclaiming balance: The urgent need for fair global trade

Culture & Lifestyle / 1y

Renowned public health expert honoured at award ceremony in Penang

Spotlight

Malaysia

Bersatu-PH tie-up a possibility as coalition seeks Malay support, analyst says

By Alfian Z.M. Tahir

Malaysia

Woman molested on her way home from work (video)

Malaysia

Court allows Daim's daughter to permanently keep passport

Malaysia

Santiago pokes holes in data centre hype, asks: Who really benefits?

By Alfian Z.M. Tahir

Malaysia

Jeweller vows to pursue Rosmah until ‘every penny’ is recovered as RM67.5m battle enters enforcement phase

Malaysia

Ambulance carrying two injured men crashes en route to hospital after MPV collision in Besut

Malaysia

Man blames 'lack of love' for sexual assault on teens

Business

BNM's OPR to stay at 2.75 pcent in 2026 amid strong domestic demand - Kenanga IB

Malaysia

Missing jewellery: Rosmah ordered to pay RM67.5 million

You may be interested

Malaysia

Retail prices of diesel, RON95 remain unchanged - at RM4.67, RM3.72 per litre

Malaysia

Shop assistant pleads guilty to machete attack on father and arson of family vehicles

Malaysia

Missing jewellery: Rosmah ordered to pay RM67.5 million

Malaysia

Johor polls: UMNO asserts independence from federal Unity Government agreement

Malaysia

EPF to shut all remittance counters nationwide from July 1 in major digital services push

Malaysia

Johor and NS polls first major test of post PAS-Bersatu political order

Malaysia

AGC: Albert Tei’s complaint against Azam Baki classified as NFA

Malaysia

Anwar’s leadership strengthens Japanese investor confidence in Malaysia — Bank Rakyat Chairman